Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension

JPH Wilding, RL Batterham, M Davies… - Diabetes, Obesity …, 2022 - Wiley Online Library
Aim To explore changes in body weight and cardiometabolic risk factors after treatment
withdrawal in the STEP 1 trial extension. Materials and Methods STEP 1 (NCT03548935) …
被引用次数：439 相关文章

Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension

JPH Wilding, RL Batterham, M Davies, LF Van Gaal… - 2022 - figshare.le.ac.uk
To explore changes in body weight and cardiometabolic risk factors after treatment
withdrawal in the STEP 1 trial extension. STEP 1 (NCT03548935) randomized 1961 adults …
[HTML] nih.gov

[HTML][HTML] Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension

JPH Wilding, RL Batterham, M Davies… - Diabetes, Obesity & …, 2022 - ncbi.nlm.nih.gov
Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial
extension - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …

Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension.

JPH Wilding, RL Batterham, M Davies… - Diabetes, Obesity & …, 2022 - search.ebscohost.com
Aim: To explore changes in body weight and cardiometabolic risk factors after treatment
withdrawal in the STEP 1 trial extension. Materials and Methods: STEP 1 (NCT03548935) …

Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension

JPH Wilding, RL Batterham, M Davies… - Diabetes, Obesity …, 2022 - discovery.ucl.ac.uk
AIM: To explore changes in body weight and cardiometabolic risk factors after treatment
withdrawal in the STEP 1 trial extension. MATERIALS AND METHODS: STEP 1 …

Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension

JPH Wilding, RL Batterham, M Davies, LF Van Gaal… - 2022 - pubmed.ncbi.nlm.nih.gov
Aim To explore changes in body weight and cardiometabolic risk factors after treatment
withdrawal in the STEP 1 trial extension. Materials and methods STEP 1 (NCT03548935) …
[PDF] bewusst-diaetfrei.de

[PDF][PDF] Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension

JPHW DM, RL Batterham, M Davies, LF Van Gaal… - 2022 - bewusst-diaetfrei.de
Aim: To explore changes in body weight and cardiometabolic risk factors after treatment
withdrawal in the STEP 1 trial extension. Materials and Methods: STEP 1 (NCT03548935) …
[PDF] sochob.cl

[PDF][PDF] Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension

JPHW DM, RL Batterham, M Davies, LF Van Gaal… - 2022 - sochob.cl
Aim: To explore changes in body weight and cardiometabolic risk factors after treatment
withdrawal in the STEP 1 trial extension. Materials and Methods: STEP 1 (NCT03548935) …

Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension

STEP 1 Study Group - Diabetes, Obesity and …, 2022 - scholars.northwestern.edu
Aim: To explore changes in body weight and cardiometabolic risk factors after treatment
withdrawal in the STEP 1 trial extension. Materials and Methods: STEP 1 (NCT03548935) …
[PDF] healthyweightclinics.com

[PDF][PDF] Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension

JPHW DM, RL Batterham, M Davies, LF Van Gaal… - 2022 - healthyweightclinics.com
Aim: To explore changes in body weight and cardiometabolic risk factors after treatment
withdrawal in the STEP 1 trial extension. Materials and Methods: STEP 1 (NCT03548935) …